Plus Therapeutics
American pharmaceutical company specializing in radiotherapeutics
Plus Therapeutics, Inc. is an American pharmaceutical company that focuses on the development and commercialization of innovative, targeted radiotherapeutics for patients with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, and operates with a mission to improve the lives of patients through the development of novel therapies.
History[edit]
Plus Therapeutics was originally founded as a biotechnology company with a focus on developing nanomedicine-based therapies. Over the years, the company has evolved its focus towards radiotherapeutics, leveraging its expertise in drug development and delivery technologies. The shift towards radiotherapeutics was driven by the potential of these therapies to provide targeted treatment options for cancers that are otherwise challenging to treat.
Research and Development[edit]
The company's research and development efforts are centered around the use of radioisotopes to deliver targeted radiation therapy directly to cancer cells. This approach aims to minimize damage to surrounding healthy tissues, thereby reducing side effects and improving patient outcomes. Plus Therapeutics is actively involved in clinical trials to evaluate the safety and efficacy of its radiotherapeutic candidates.
Radiotherapeutic Platforms[edit]
Plus Therapeutics utilizes proprietary platforms to develop its radiotherapeutic products. These platforms are designed to enhance the delivery and targeting of radioisotopes to cancer cells. The company's lead product candidates are being developed for the treatment of glioblastoma, a highly aggressive form of brain cancer, and other solid tumors.
Products[edit]
The company's product pipeline includes several investigational radiotherapeutics that are in various stages of clinical development. These products are designed to address unmet medical needs in oncology by providing new treatment options for patients with limited alternatives.
Corporate Strategy[edit]
Plus Therapeutics' corporate strategy involves strategic partnerships and collaborations with leading academic institutions and research organizations. These partnerships are aimed at advancing the development of its radiotherapeutic candidates and expanding its pipeline.
Related pages[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
